Literature DB >> 23989070

Validation of the Walking Impairment Questionnaire for Spanish patients.

Francisco S Lozano1, José R March, José R González-Porras, Eduardo Carrasco, José M Lobos, Alix Areitio-Aurtena.   

Abstract

BACKGROUND: The Walking Impairment Questionnaire (WIQ) is a short, easy to complete, disease-specific questionnaire to assess intermittent claudication. A Spanish version of the WIQ for Hispanic Americans has recently been validated in Texas, but it needs to be validated for European Spanish people. PATIENTS AND METHODS: After translation and cultural adaptation of the WIQ, 920 patients with intermittent claudication (ankle brachial index < 0.9) completed two questionnaires (Spanish version of the WIQ and European Quality of Life 5 Dimension [EQ-5D]). The validity of the WIQ was determined by correlating WIQ and EQ-5D. Test-retest reliability and internal consistency were determined using the intra-class correlation coefficient (ICC) and Cronbach's alpha, respectively.
RESULTS: The three domains of the WIQ were moderately correlated with the EQ-5D health outcome (r = 0.54 to 0.60; p < 0.001). Test-retest reliabilities ranged from ICC = 0.89 to 0.91 and internal consistency (Cronbach's alpha = 0.92) was high.
CONCLUSIONS: The Spanish version of the WIQ for European Spanish patients was valid and reproducible, suggesting that it could be used in Spanish patients with intermittent claudication.

Entities:  

Mesh:

Year:  2013        PMID: 23989070     DOI: 10.1024/0301-1526/a000300

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  2 in total

1.  Peripheral arterial disease screening and diagnostic practice: A scoping review.

Authors:  Cornelius M Donohue; Joseph V Adler; Laura L Bolton
Journal:  Int Wound J       Date:  2019-11-03       Impact factor: 3.315

2.  Validation of the Korean version of the walking impairment questionnaire in patients with peripheral arterial disease.

Authors:  Chanjoong Choi; Taeseung Lee; Seung-Kee Min; Ahram Han; Song-Yi Kim; Sang-Il Min; Jongwon Ha; In Mok Jung
Journal:  Ann Surg Treat Res       Date:  2017-07-28       Impact factor: 1.859

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.